Summary
We report on a 25 yr old woman with primary autoimmune hyperthyroidism who was treated with carbimazole. Forty-three days later she developed agranulocytosis (64 × 106/l). With 4 days treatment with recombinant human Granulocyte Colony Stimulating factor the granulocyte count rose to normal — 4,350 cells X 106/l. This is considerably faster than the rate of spontaneous recovery which usually takes one to 2 weeks.
Similar content being viewed by others
References
Herbert, V. The Blood (Thyroid disease: disorders that cause thyrotoxicosis) in: Werner’s The Thyroid. Ed S. H. Ingbar and L. E. Bravermann. 5th Edition. J. P. Lippincott. Philadelphia. 1986. PP. 878–884.
Tajiri, J., Noguchi, S., Murakami, T., Murakami, N. Antithyroid drug-induced agranulocytosis. Arch. Intern. Med. 1990; 150: 621–624.
Cooper, D. S. Antithyroid drugs. N. Engl. J. Med. 1984; 311: 1353–1362.
Weitzman, S. A., Stossel, T. P. Drug induced immunological neutropaenia. Lancet 1978; 11: 1068–1072.
Metcalf, D. Haemopoietic growth factors 2: Clinical applications. Lancet 1989; 11: 885–887.
Heinrich, B., Gross, M., Goebel, F. D. Methimazole-induced agranulocytosis and granulocyte-colony stimulating factor. Ann. Intern. Med. 1989; 111: 621–622.
Tamai, H., Mukuta, T., Matsubayashi, S. et al. Treatment of methimazole-induced agranulocytosis using human granulocyte colony stimulating factor (rhg-CSF). J. Clin. Endocrin. Metab. 1993; 77: 1356–1360.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
O’Hare, J.A., Azher, T. Carbimazole induced agranulocytosis: Rescue with human recombinant Granulocyte Colony Stimulating factor. I.J.M.S. 166, 239–240 (1997). https://doi.org/10.1007/BF02944242
Issue Date:
DOI: https://doi.org/10.1007/BF02944242